AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] abrdn Japan Equity Fund, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Ajmera Radhika, a director of ABRDN Japan Equity Fund, Inc. (JEQ), reported a disposition of 1,090 shares of JEQ on 09/03/2025 at a price of $8.04 per share. The sale was made in connection with the Fund's issuer tender offer described in the Schedule TO filed August 1, 2025, and the reporting person notes the Fund will purchase a prorated portion of tendered shares. A preliminary proration factor of 63.63% is reported and the form states an amended Form 4 will be filed if needed to reflect the final proration. Following the reported transaction the filing shows 623.8527 shares beneficially owned, held directly. The Form 4 was signed by Lucia Sitar as POA on 09/05/2025.

Ajmera Radhika, amministratrice di ABRDN Japan Equity Fund, Inc. (JEQ), ha segnalato la cessione di 1.090 azioni JEQ in data 09/03/2025 al prezzo di $8.04 per azione. La vendita è stata effettuata in relazione all'offerta di acquisto dell'emittente descritta nello Schedule TO depositato il 1° agosto 2025; la dichiarante osserva che il Fondo acquisterà una quota proporzionale delle azioni offerte in opzione. È riportato un fattore di riproporzionamento preliminare del 63,63% e il modulo indica che verrà presentato un Form 4 emendato, se necessario, per riflettere la riproporzionamento finale. Dopo l'operazione segnalata il deposito indica la detenzione beneficiaria di 623,8527 azioni, detenute direttamente. Il Form 4 è stato firmato da Lucia Sitar in qualità di POA il 09/05/2025.

Ajmera Radhika, directora de ABRDN Japan Equity Fund, Inc. (JEQ), informó la enajenación de 1.090 acciones de JEQ el 09/03/2025 a un precio de $8.04 por acción. La venta se realizó en relación con la oferta de compra del emisor descrita en el Schedule TO presentado el 1 de agosto de 2025, y la informante señala que el Fondo comprará una porción prorrateada de las acciones ofrecidas. Se reporta un factor de prorrateo preliminar del 63,63% y el formulario indica que se presentará un Form 4 enmendado, si es necesario, para reflejar el prorrateo final. Tras la transacción registrada, el documento muestra la tenencia beneficiaria de 623,8527 acciones, mantenidas directamente. El Form 4 fue firmado por Lucia Sitar como POA el 09/05/2025.

Ajmera RadhikaëŠ� ABRDN Japan Equity Fund, Inc.(JEQ)ì� ì´ì‚¬ë¡œì„œ 2025-09-03ì—� JEQ ì£¼ì‹ 1,090주를 주당 $8.04ì—� 처분했다ê³� 보고했습니다. ì´ë²ˆ 매ê°ì€ 2025ë…� 8ì›� 1ì� 제출ë� Schedule TOì—� 설명ë� íŽ€ë“œì˜ ë°œí–‰ìž� 공개매수(issuer tender offer)와 ê´€ë ¨ëœ ê²ƒìœ¼ë¡�, ë³´ê³ ìžëŠ” 펀드가 ì‘모ë� 주ì‹ì� 비례 ë°°ë¶„(prorated)ë� ì¼ë¶€ë¥� 매수í•� 것ì´ë¼ê³  명시했습니다. 예비 ë°°ë¶„ 비율ë¡� 63.63%ê°€ ë³´ê³ ë˜ì—ˆìœ¼ë©°, 최종 ë°°ë¶„ì� ë°˜ì˜í•˜ê¸° 위해 í•„ìš” ì‹� 수정ë� Form 4ê°€ 제출ë� 것ì´ë¼ê³  기재ë˜ì–´ 있습니다. ë³´ê³ ë� 거래 í›� 보유 실질수ìµê¶Œì€ 623.8527주ì´ê³�, ì§ìΪ 보유 중입니다. Form 4ëŠ� 2025-09-05ì—� Lucia Sitarê°€ POAë¡� 서명했습니다.

Ajmera Radhika, administratrice d'ABRDN Japan Equity Fund, Inc. (JEQ), a déclaré la cession de 1 090 actions JEQ le 09/03/2025 au prix de 8,04 $ par action. La vente a été effectuée dans le cadre de l'offre publique d'achat de l'émetteur décrite dans le Schedule TO déposé le 1er août 2025 ; la déclarente précise que le Fonds achètera une portion proratisée des actions présentées. Un facteur de proratisation préliminaire de 63,63% est indiqué et le formulaire précise qu'un Form 4 modifié sera déposé si nécessaire pour refléter la proratisation finale. Après la transaction signalée, le dossier indique une détention bénéficiaire de 623,8527 actions, détenues directement. Le Form 4 a été signé par Lucia Sitar en tant que POA le 09/05/2025.

Ajmera Radhika, Direktorin von ABRDN Japan Equity Fund, Inc. (JEQ), meldete am 09/03/2025 die Veräußerung von 1.090 JEQ-Aktien zu $8.04 je Aktie. Der Verkauf erfolgte im Zusammenhang mit dem Emittenten-Angebot (issuer tender offer), das im Schedule TO vom 1. August 2025 beschrieben ist; die Meldende weist darauf hin, dass der Fonds einen anteiligen (prorated) Teil der angebotenen Aktien kaufen wird. Ein vorläufiger Quotierungsfaktor von 63,63% wird angegeben, und im Formular heißt es, dass gegebenenfalls ein berichtigtes Form 4 zur Abbildung der endgültigen Quotierung eingereicht wird. Nach der gemeldeten Transaktion werden 623,8527 Aktien als wirtschaftlich gehalten angegeben, gehalten direkt. Das Form 4 wurde am 09/05/2025 von Lucia Sitar als POA unterzeichnet.

Positive
  • Transaction executed via issuer tender offer, reducing likelihood the sale reflects undisclosed private information
  • Filing discloses preliminary proration factor (63.63%) and commits to amend if final proration changes, supporting transparency
  • Timely disclosure filed and signed by POA within two days of the transaction date
Negative
  • None.

Insights

TL;DR: Director sold 1,090 JEQ shares via the issuer's tender offer; transaction appears procedural and subject to proration.

The transaction is a direct disposition executed under the issuer's tender offer rather than an open-market trade, which reduces the risk that the sale signals private negative information. The reported preliminary proration factor of 63.63% means the Fund will only purchase a prorated portion of tendered shares; the filer may therefore tender more shares than were ultimately purchased. The filing explicitly states an amended Form 4 will be filed if the final proration differs, which preserves disclosure accuracy. Ownership post-transaction is reported as 623.8527 shares directly held.

TL;DR: Insider disposal was executed through a corporate tender offer; disclosure is timely and includes proration caveat.

This Form 4 documents a routine compliance disclosure for a director participating in an issuer-sponsored tender offer. The filing identifies the transaction date, price ($8.04), and the preliminary proration factor (63.63%), and it notes a possible amendment to reconcile final share quantities. The signature by a power of attorney on 09/05/2025 fulfills the filing execution requirement. There are no other governance actions or departures disclosed.

Ajmera Radhika, amministratrice di ABRDN Japan Equity Fund, Inc. (JEQ), ha segnalato la cessione di 1.090 azioni JEQ in data 09/03/2025 al prezzo di $8.04 per azione. La vendita è stata effettuata in relazione all'offerta di acquisto dell'emittente descritta nello Schedule TO depositato il 1° agosto 2025; la dichiarante osserva che il Fondo acquisterà una quota proporzionale delle azioni offerte in opzione. È riportato un fattore di riproporzionamento preliminare del 63,63% e il modulo indica che verrà presentato un Form 4 emendato, se necessario, per riflettere la riproporzionamento finale. Dopo l'operazione segnalata il deposito indica la detenzione beneficiaria di 623,8527 azioni, detenute direttamente. Il Form 4 è stato firmato da Lucia Sitar in qualità di POA il 09/05/2025.

Ajmera Radhika, directora de ABRDN Japan Equity Fund, Inc. (JEQ), informó la enajenación de 1.090 acciones de JEQ el 09/03/2025 a un precio de $8.04 por acción. La venta se realizó en relación con la oferta de compra del emisor descrita en el Schedule TO presentado el 1 de agosto de 2025, y la informante señala que el Fondo comprará una porción prorrateada de las acciones ofrecidas. Se reporta un factor de prorrateo preliminar del 63,63% y el formulario indica que se presentará un Form 4 enmendado, si es necesario, para reflejar el prorrateo final. Tras la transacción registrada, el documento muestra la tenencia beneficiaria de 623,8527 acciones, mantenidas directamente. El Form 4 fue firmado por Lucia Sitar como POA el 09/05/2025.

Ajmera RadhikaëŠ� ABRDN Japan Equity Fund, Inc.(JEQ)ì� ì´ì‚¬ë¡œì„œ 2025-09-03ì—� JEQ ì£¼ì‹ 1,090주를 주당 $8.04ì—� 처분했다ê³� 보고했습니다. ì´ë²ˆ 매ê°ì€ 2025ë…� 8ì›� 1ì� 제출ë� Schedule TOì—� 설명ë� íŽ€ë“œì˜ ë°œí–‰ìž� 공개매수(issuer tender offer)와 ê´€ë ¨ëœ ê²ƒìœ¼ë¡�, ë³´ê³ ìžëŠ” 펀드가 ì‘모ë� 주ì‹ì� 비례 ë°°ë¶„(prorated)ë� ì¼ë¶€ë¥� 매수í•� 것ì´ë¼ê³  명시했습니다. 예비 ë°°ë¶„ 비율ë¡� 63.63%ê°€ ë³´ê³ ë˜ì—ˆìœ¼ë©°, 최종 ë°°ë¶„ì� ë°˜ì˜í•˜ê¸° 위해 í•„ìš” ì‹� 수정ë� Form 4ê°€ 제출ë� 것ì´ë¼ê³  기재ë˜ì–´ 있습니다. ë³´ê³ ë� 거래 í›� 보유 실질수ìµê¶Œì€ 623.8527주ì´ê³�, ì§ìΪ 보유 중입니다. Form 4ëŠ� 2025-09-05ì—� Lucia Sitarê°€ POAë¡� 서명했습니다.

Ajmera Radhika, administratrice d'ABRDN Japan Equity Fund, Inc. (JEQ), a déclaré la cession de 1 090 actions JEQ le 09/03/2025 au prix de 8,04 $ par action. La vente a été effectuée dans le cadre de l'offre publique d'achat de l'émetteur décrite dans le Schedule TO déposé le 1er août 2025 ; la déclarente précise que le Fonds achètera une portion proratisée des actions présentées. Un facteur de proratisation préliminaire de 63,63% est indiqué et le formulaire précise qu'un Form 4 modifié sera déposé si nécessaire pour refléter la proratisation finale. Après la transaction signalée, le dossier indique une détention bénéficiaire de 623,8527 actions, détenues directement. Le Form 4 a été signé par Lucia Sitar en tant que POA le 09/05/2025.

Ajmera Radhika, Direktorin von ABRDN Japan Equity Fund, Inc. (JEQ), meldete am 09/03/2025 die Veräußerung von 1.090 JEQ-Aktien zu $8.04 je Aktie. Der Verkauf erfolgte im Zusammenhang mit dem Emittenten-Angebot (issuer tender offer), das im Schedule TO vom 1. August 2025 beschrieben ist; die Meldende weist darauf hin, dass der Fonds einen anteiligen (prorated) Teil der angebotenen Aktien kaufen wird. Ein vorläufiger Quotierungsfaktor von 63,63% wird angegeben, und im Formular heißt es, dass gegebenenfalls ein berichtigtes Form 4 zur Abbildung der endgültigen Quotierung eingereicht wird. Nach der gemeldeten Transaktion werden 623,8527 Aktien als wirtschaftlich gehalten angegeben, gehalten direkt. Das Form 4 wurde am 09/05/2025 von Lucia Sitar als POA unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ajmera Radhika

(Last) (First) (Middle)
C/O ABRDN
1900 MARKET STREET, SUITE 200

(Street)
PHILADELPHIA PA 19103

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ABRDN JAPAN EQUITY FUND, INC. [ JEQ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/03/2025 D 1,090(1) D $8.04 623.8527 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The amount reported represents the estimated number of shares tendered to the Aberdeen Japan Equity Fund, Inc. (the "Fund") in connection with the issuer tender offer by the Fund pursuant to the Tender Offer Statement on Schedule TO filed with the Securities and Exchange Commission on August 1, 2025 (the "Tender Offer"). The Fund will purchase only a prorated portion of the shares properly tendered by each tendering stockholder. Based on a preliminary count reported by the Fund, the preliminary proration factor is 63.63%. If necessary, an amended Form 4 will be filed to report the number of shares actually disposed of by the reporting person in connection with the Tender Offer once the final proration factor is determined.
/s/ Lucia Sitar, by POA from Reporting Person 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ajmera Radhika report on Form 4 for JEQ?

The filing reports a disposition of 1,090 shares of JEQ on 09/03/2025 at $8.04 per share in connection with the Fund's tender offer.

Why were the JEQ shares sold on the Form 4?

The sale was made in connection with the issuer tender offer referenced in the Schedule TO filed August 1, 2025; the Fund will purchase a prorated portion of tendered shares.

What proration factor is mentioned in the Form 4?

A preliminary proration factor of 63.63% is reported and the filer states an amended Form 4 will be filed if necessary when the final proration is determined.

How many JEQ shares does the reporting person own after the reported transaction?

The Form 4 reports 623.8527 shares beneficially owned following the reported transaction, held directly.

Who signed the Form 4 and when?

The form was signed by Lucia Sitar as power of attorney for the reporting person on 09/05/2025.
abrdn Japan Equity Fund

NYSE:JEQ

JEQ Rankings

JEQ Latest News

JEQ Latest SEC Filings

JEQ Stock Data

114.02M
13.85M
0.01%
69.96%
0.33%
Asset Management
Financial Services
Singapore
Singapore